Key Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378 Hold
1
– – ﹤0.01% 1247
2026
Q2
$294 Hold
1
– – ﹤0.01% 1294
2026
Q1
$279 Hold
1
– – ﹤0.01% 1335
2025
Q4
$303 Hold
1
– – ﹤0.01% 1355
2025
Q3
$298 Hold
1
– – ﹤0.01% 1374
2025
Q2
$241 Hold
1
– – ﹤0.01% 1374
2025
Q1
$244 Hold
1
– – ﹤0.01% 1333
2024
Q4
$329 Hold
1
– – ﹤0.01% 1323
2024
Q3
$335 Hold
1
– – ﹤0.01% 1292
2024
Q2
$273 Buy
+1
New +$291 ﹤0.01% 1287

Other funds holding BIO

Key Financial's BIO Position: Q3 2026 in Review

Key Financial held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 1 share worth $378. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Key Financial first reported a position in BIO in Q2 2024 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Key Financial held 1 share of Bio-Rad Laboratories Class A worth $378 as of Q3 2026.
  • Key Financial left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1247 holding.
  • Key Financial first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and has held it in 10 quarters since.
  • 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.